Stockscreener 앱 받기
237.03
1.37%
-3.30
시간 외 거래:
238.10
1.07
+0.45%
전일 마감가:
$240.33
열려 있는:
$238.85
하루 거래량:
1.19M
Relative Volume:
1.26
시가총액:
$17.09B
수익:
$3.07B
순이익/손실:
$493.70M
주가수익비율:
34.89
EPS:
6.7935
순현금흐름:
$468.90M
1주 성능:
+0.67%
1개월 성능:
-1.70%
6개월 성능:
-6.99%
1년 성능:
+4.18%
1일 변동 폭
$236.12
$241.40
1주일 범위
$234.57
$244.28
52주 변동 폭
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
237.03 | 17.09B | 3.07B | 493.70M | 468.90M | 6.7935 |
ISRG
Intuitive Surgical Inc
|
477.97 | 169.76B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.13 | 43.84B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
73.65 | 35.90B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.73 | 34.68B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
225.99 | 32.92B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Exton-based West Pharmaceutical reports higher Q4 sales, earnings - MSN
Here is why West Pharmaceutical Services, Inc. (WST) is strongly favored by hedge funds - MSN
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Here's Why You Should Add McKesson Stock to Your Portfolio Now - TradingView
West Pharmaceutical Services, Inc. $WST Shares Purchased by JPMorgan Chase & Co. - MarketBeat
West CEO Eric Green plans retirement pending successor search - MSN
3 Overvalued Stocks: High P/E Ratios Signal Risk Amid Slowing GrowthNews and Statistics - IndexBox
West Pharmaceutical Services expert to present medical device biocompatibility strategy at key summit - Traders Union
West Pharmaceutical Stock (ISIN: US9523901012) Faces Pressure Amid Pharma Supply Chain Shifts and Ea - AD HOC NEWS
West Pharmaceutical Services at KeyBanc Forum: Strategic Growth Insights By Investing.com - Investing.com Canada
West Pharmaceutical declares $0.22 dividend - MSN
West CEO Eric Green Plans Retirement Pending Successor Search - MyChesCo
West Pharmaceutical declares dividend, authorizes $1B buyback - MSN
West Pharmaceutical Services showcases device innovation at COPHEX Korea event - Traders Union
Moore Capital Management LP Purchases New Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Holocene Advisors LP Takes $49.09 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Improved Investor Confidence Boosted West Pharmaceutical Services (WST) - MSN
West Pharmaceutical Services urges industry to adapt as USP draft chapters reshape contamination control - Traders Union
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
The Zacks Analyst Blog Highlights Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services - Yahoo Finance
Iron Triangle Partners LP Purchases New Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
Hillman Capital Management Inc. Takes $2.70 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Will CEO Succession and Chair Role Debate Reshape West Pharmaceutical’s Governance Story (WST)? - Yahoo Finance
Cinctive Capital Management LP Makes New $3.76 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical CEO Eric Green to retire in second half 2026 - Investing.com Nigeria
How Leadership Transition And Governance Debate At West Pharmaceutical (WST) Has Changed Its Investment Story - simplywall.st
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bamco Inc. NY Sells 6,716 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Stake Lifted by Ossiam - MarketBeat
West Pharmaceutical Governance Vote Puts Leadership Structure And Valuation In Focus - simplywall.st
Brown Brothers Harriman & Co. Has $64.89 Million Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services secures top supplier and innovation awards in drug delivery - Traders Union
3 Dividend Aristocrats to Buy Now Amid the Middle East Crisis - The Globe and Mail
Are Wall Street analysts bullish on West Pharmaceutical Services stock? - MSN
West Pharmaceutical Services Forms Death Cross, Signals Bearish Trend Ahead - Markets Mojo
How Is West Pharmaceutical's Stock Performance Compared to Other Healthcare Stocks? - Yahoo Finance
Franklin Resources Inc. Decreases Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
John Chevedden Submits Shareholder Proposal to West Pharmaceutical - marketscreener.com
West Pharmaceutical Receives Shareholder Proposal from John Chevedden - marketscreener.com
West Pharmaceutical (NYSE: WST) 2025 growth, CEO retirement plan - Stock Titan
Swiss National Bank Trims Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Russell Investments Group Ltd. Sells 22,663 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Schroder Investment Management Group Acquires 23,474 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Korea Investment CORP Increases Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Compelling Arguments for Including West Pharmaceutical Shares in Your Investment Portfolio Today - Bitget
Reasons to Add West Pharmaceutical Stock to Your Portfolio Right Now - Yahoo Finance
Drug Development Services Q4 2025: Revenue Beat, Stock Prices FallNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
West Pharmaceutical Services Hits Day Low at $228.40 Amid Price Pressure - Markets Mojo
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
1.06%
자본화:
|
볼륨(24시간):